Sie sind auf Seite 1von 737

BADRAWY MRCP Revision

BADRAWY MRCP Revision


This is a collection of commonly
tested facts for part 1
MRCP ...including the 100
commonly tested
facts & > 200 more....
1a

BADRAWY MRCP Revision

a must read before part 1 ...


U'll find at least 20-30
Questions in your MRCP 1
exam from these notes.

1b

BADRAWY MRCP Revision

Somatisation vs
hypochondria
2a

BADRAWY MRCP Revision

Somatisation = patient
concerned about Symptoms.
HypochonDria = patient
concerned about underlying
Disease eg Cancer.
2b

BADRAWY MRCP Revision

DiGeorge syndrome =
affects what type of cell?
3a

BADRAWY MRCP Revision

- a T-cell disorder

3b

BADRAWY MRCP Revision

Antithrombotic therapy in
bioprosthetic vs
mechanical heart valves
4a

BADRAWY MRCP Revision

- bioprosthetic: aspirin mechanical: warfarin +


aspirin
4b

BADRAWY MRCP Revision

Goodpasture's syndrome histology?


5a

BADRAWY MRCP Revision

- IgG deposits on renal


biopsy - anti-GBM
antibodies
5b

BADRAWY MRCP Revision

Adrenaline induced
ischaemia treatment
6a

BADRAWY MRCP Revision

- phentolamine

6b

BADRAWY MRCP Revision

Complete heart block


following a MI?
7a

BADRAWY MRCP Revision

- right coronary artery


lesion
7b

BADRAWY MRCP Revision

Wilson's disease: diagnosis

8a

BADRAWY MRCP Revision

- serum caeruloplasmin is
decreased
8b

BADRAWY MRCP Revision

Fluctuating
confusion/consciousness in
elderly plus/minus
deterioration ?
9a

BADRAWY MRCP Revision

chronic subdural. Can last


even longer than 6 months
9b

BADRAWY MRCP Revision

Acute promyelocytic
leukaemia translocation
10a

BADRAWY MRCP Revision

- t(15;17)

10b

BADRAWY MRCP Revision

Dermatophyte nail
infections Rx
11a

BADRAWY MRCP Revision

- use oral terbinafine

11b

BADRAWY MRCP Revision

Actions of BNP

12a

BADRAWY MRCP Revision

- vasodilator - diuretic and


natriuretic - suppresses
both sympathetic tone and
the renin-angiotensinaldosterone system
12b

BADRAWY MRCP Revision

Burning thigh pain - ?nerve


compression
13a

BADRAWY MRCP Revision

? meralgia paraesthetica lateral cutaneous nerve of


thigh compression
13b

BADRAWY MRCP Revision

URTI symptoms +
amoxicillin --> rash
14a

BADRAWY MRCP Revision

?glandular fever

14b

BADRAWY MRCP Revision

IgM paraproteinaemia -

15a

BADRAWY MRCP Revision

?Waldenstrom's
macroglobulinaemia
15b

BADRAWY MRCP Revision

Absolute risk reduction =

16a

BADRAWY MRCP Revision

= (Control event rate) (Experimental event rate)


16b

BADRAWY MRCP Revision

Terlipressin - MoA?

17a

BADRAWY MRCP Revision

= constriction of the
splanchnic vessels
17b

BADRAWY MRCP Revision

Localising bitemporal
hemianopia - upper
quadrant defect > lower
quadrant defect.
18a

BADRAWY MRCP Revision

= inferior chiasmal
compression, commonly a
pituitary tumour
18b

BADRAWY MRCP Revision

Tear-drop poikilocytes ?

19a

BADRAWY MRCP Revision

= myelofibrosis

19b

BADRAWY MRCP Revision

Localising bitemporal
hemianopia - upper
quadrant defect > lower
quadrant defect.
20a

BADRAWY MRCP Revision

= superior chiasmal
compression, commonly a
craniopharyngioma
20b

BADRAWY MRCP Revision

Imatinib - MoA

21a

BADRAWY MRCP Revision

= tyrosine kinase inhibitor


used in CML
21b

BADRAWY MRCP Revision

Flushing, diarrhoea,
bronchospasm, tricuspid
stenosis, pellagra diagnosis?
22a

BADRAWY MRCP Revision

--> carcinoid with liver


mets
22b

BADRAWY MRCP Revision

Flash pulmonary oedema,


U&Es worse on ACE
inhibitor, asymmetrical
kidneys: ?diagnosis
23a

BADRAWY MRCP Revision

--> renal artery stenosis do MR angiography


23b

BADRAWY MRCP Revision

Collapse + ARF =

24a

BADRAWY MRCP Revision

--> rhabdomyolysis - treat


with IV fluids
24b

BADRAWY MRCP Revision

Statistical power =

25a

BADRAWY MRCP Revision

1 - the probability of a type


II error
25b

BADRAWY MRCP Revision

Sarcoidosis CXR stages

26a

BADRAWY MRCP Revision

1 = BHL - 2 = BHL +
infiltrates - 3 = infiltrates 4 = fibrosis
26b

BADRAWY MRCP Revision

Calculating breakthrough
morphine dose?
27a

BADRAWY MRCP Revision

1/6th of daily morphine


dose
27b

BADRAWY MRCP Revision

Post-natal depression
incidence?
28a

BADRAWY MRCP Revision

10% of women

28b

BADRAWY MRCP Revision

COPD - when to start


LTOT?
29a

BADRAWY MRCP Revision

2 measurements of pO2 <


7.3 kPa
29b

BADRAWY MRCP Revision

Stroke thrombolysis time


limit?
30a

BADRAWY MRCP Revision

4.5 hours

30b

BADRAWY MRCP Revision

1mg prednisolone = ?
hydrocortisone
31a

BADRAWY MRCP Revision

4mg hydrocortisone

31b

BADRAWY MRCP Revision

Finasteride MoA

32a

BADRAWY MRCP Revision

5 alpha-reductase inhibitor
- inhibits conversion of
testosterone to
dihydrotestosterone
32b

BADRAWY MRCP Revision

Finasteride treatment of
BPH may take how long
before results are seen?
33a

BADRAWY MRCP Revision

6 months

33b

BADRAWY MRCP Revision

DVLA restriction postseizure


34a

BADRAWY MRCP Revision

6 months

34b

BADRAWY MRCP Revision

Rx for Hypertension in
diabetics 35a

BADRAWY MRCP Revision

ACE-inhibitors are firstline regardless of age


35b

BADRAWY MRCP Revision

Dysphagia affecting both


solids and liquids from the
start - think?
36a

BADRAWY MRCP Revision

achalasia

36b

BADRAWY MRCP Revision

Loss of corneal reflex - key


differential?
37a

BADRAWY MRCP Revision

acoustic neuroma

37b

BADRAWY MRCP Revision

Factor V Leiden mutation


results in?
38a

BADRAWY MRCP Revision

activated protein C
resistance
38b

BADRAWY MRCP Revision

Key treatments in migraine


- acute vs prophylactic
39a

BADRAWY MRCP Revision

acute: 5-HT1 agonist prophylaxis: beta-blocker


39b

BADRAWY MRCP Revision

Congenital heart disease acyanotic - most common


cause:
40a

BADRAWY MRCP Revision

acyanotic: VSD most


common cause
40b

BADRAWY MRCP Revision

Glitazones: MoA

41a

BADRAWY MRCP Revision

agonists of PPAR-gamma
receptors
41b

BADRAWY MRCP Revision

Atrial fibrillation cardioversion rx:


42a

BADRAWY MRCP Revision

amiodarone + flecainide

42b

BADRAWY MRCP Revision

Adult Life Support (ALS)


adrenaline doses 43a

BADRAWY MRCP Revision

anaphylaxis: 0.5ml 1:1,000


IM - cardiac arrest: 10ml
1:10,000 IV or 1ml of
1:1000 IV
43b

BADRAWY MRCP Revision

Bartter's syndrome ?

44a

BADRAWY MRCP Revision

AR inherited cause of
hypokalaemia associated
with normotension
44b

BADRAWY MRCP Revision

Miller Fisher syndrome CFs?


45a

BADRAWY MRCP Revision

areflexia, ataxia,
ophthalmoplegia
45b

BADRAWY MRCP Revision

Polycythaemia rubra vera


progression?
46a

BADRAWY MRCP Revision

around 5-15% progress to


myelofibrosis or AML
46b

BADRAWY MRCP Revision

malt workers' lung pathogen


47a

BADRAWY MRCP Revision

Aspergillus clavatus

47b

BADRAWY MRCP Revision

Urticaria - common drug


cause?
48a

BADRAWY MRCP Revision

Aspirin

48b

BADRAWY MRCP Revision

Antiphospholipid
syndrome in pregnancy
treatment
49a

BADRAWY MRCP Revision

aspirin + LMWH

49b

BADRAWY MRCP Revision

Causes of raised transfer


factor?
50a

BADRAWY MRCP Revision

asthma, haemorrhage, leftto-right shunts,


polycythaemia
50b

BADRAWY MRCP Revision

Beta-blocker overdose
management:
51a

BADRAWY MRCP Revision

atropine + glucagon

51b

BADRAWY MRCP Revision

Hereditary haemorrhagic
telangiectasia - inheritance
52a

BADRAWY MRCP Revision

autosomal dominant

52b

BADRAWY MRCP Revision

Alpha-1 antitrypsin
deficiency inheritance
53a

BADRAWY MRCP Revision

autosomal recessive / codominant


53b

BADRAWY MRCP Revision

Aortic stenosis
management:
54a

BADRAWY MRCP Revision

AVR if symptomatic,
otherwise cut-off is
gradient of 50 mmHg
54b

BADRAWY MRCP Revision

Live attenuated vaccines -

55a

BADRAWY MRCP Revision

BCG - MMR - oral polio yellow fever - oral typhoid


55b

BADRAWY MRCP Revision

Atrial fibrillation: rate


control rx 56a

BADRAWY MRCP Revision

beta blockers (preferable to


digoxin)
56b

BADRAWY MRCP Revision

Aortic stenosis - most


common cause <65 yrs:
57a

BADRAWY MRCP Revision

bicuspid aortic valve

57b

BADRAWY MRCP Revision

Most common cardiac


defect in Turner's
syndrome?
58a

BADRAWY MRCP Revision

Bicuspid aortic valve

58b

BADRAWY MRCP Revision

Porphyria cutanea tarda CP?


59a

BADRAWY MRCP Revision

Bullae on hands ,blistering


photosensitive rash hypertrichosis hyperpigmentation, fragile
SKIN torn by minor trauma
59b

BADRAWY MRCP Revision

Amiodarone MoA

60a

BADRAWY MRCP Revision

Blocks potassium channels

60b

BADRAWY MRCP Revision

Visual changes secondary


to drugs - blue vision?
Yellow-green vision?
61a

BADRAWY MRCP Revision

blue vision: Viagra ('the


blue pill') - yellow-green
vision: digoxin
61b

BADRAWY MRCP Revision

HRT: adding a progestogen


increases the risk of?
62a

BADRAWY MRCP Revision

breast cancer

62b

BADRAWY MRCP Revision

Common cause of tumour


lysis syndrome?
63a

BADRAWY MRCP Revision

Burkitt's lymphoma

63b

BADRAWY MRCP Revision

EBV: associated
malignancies?
64a

BADRAWY MRCP Revision

Burkitt's lymphoma Hodgkin's lymphoma nasopharyngeal carcinoma


64b

BADRAWY MRCP Revision

Variables used to calculate


eGFR?
65a

BADRAWY MRCP Revision

CAGE - Creatinine, Age,


Gender, Ethnicity
65b

BADRAWY MRCP Revision

Aortic stenosis - most


common cause >65 yrs:
66a

BADRAWY MRCP Revision

calcification

66b

BADRAWY MRCP Revision

What drugs are now


preferred to thiazides in the
treatment of hypertension?
67a

BADRAWY MRCP Revision

Calcium channel blockers

67b

BADRAWY MRCP Revision

DVLA advice post CVA:

68a

BADRAWY MRCP Revision

cannot drive for 1 month

68b

BADRAWY MRCP Revision

DVLA advice following


angioplasty 69a

BADRAWY MRCP Revision

cannot drive for 1 week

69b

BADRAWY MRCP Revision

DVLA advice post multiple


TIAs:
70a

BADRAWY MRCP Revision

cannot drive for 3 months

70b

BADRAWY MRCP Revision

DVLA advice post MI -

71a

BADRAWY MRCP Revision

cannot drive for 4 weeks

71b

BADRAWY MRCP Revision

Epilepsy medication: firstline - partial seizure:


72a

BADRAWY MRCP Revision

carbamazepine

72b

BADRAWY MRCP Revision

Trigeminal neuralgia first-line Rx?


73a

BADRAWY MRCP Revision

carbamazepine

73b

BADRAWY MRCP Revision

Trastuzumab (Herceptin) important SE?


74a

BADRAWY MRCP Revision

cardiotoxicity

74b

BADRAWY MRCP Revision

Schistosoma haematobium

75a

BADRAWY MRCP Revision

causes haematuria

75b

BADRAWY MRCP Revision

Horner's syndrome anhydrosis of head, arm,


trunk =
76a

BADRAWY MRCP Revision

central lesion: stroke,


syringomyelia
76b

BADRAWY MRCP Revision

Chickenpox exposure in
pregnancy - first step?
77a

BADRAWY MRCP Revision

check antibodies

77b

BADRAWY MRCP Revision

CLL - treatment?

78a

BADRAWY MRCP Revision

chlorambucil

78b

BADRAWY MRCP Revision

ADPKD type 1
chromosome
79a

BADRAWY MRCP Revision

chromosome 16 = 85% of
cases
79b

BADRAWY MRCP Revision

Chemo agent associated


with hypomagnesaemia?
80a

BADRAWY MRCP Revision

Cisplatin

80b

BADRAWY MRCP Revision

Rx Infertility in PCOS -

81a

BADRAWY MRCP Revision

clomifene is superior to
metformin
81b

BADRAWY MRCP Revision

JVP: C wave - physiological


correlate
82a

BADRAWY MRCP Revision

closure of the tricuspid


valve
82b

BADRAWY MRCP Revision

Episodic eye pain,


lacrimation, nasal
stuffiness occurring daily ?diagnosis
83a

BADRAWY MRCP Revision

cluster headache

83b

BADRAWY MRCP Revision

Burkitt's lymphoma - gene


translocation?
84a

BADRAWY MRCP Revision

c-myc

84b

BADRAWY MRCP Revision

Animal bite treatment

85a

BADRAWY MRCP Revision

co-amoxiclav

85b

BADRAWY MRCP Revision

Drug metabolism - phase II


components?
86a

BADRAWY MRCP Revision

conjugation

86b

BADRAWY MRCP Revision

Viagra contraindications

87a

BADRAWY MRCP Revision

contraindicated by nitrates
and nicorandil
87b

BADRAWY MRCP Revision

Main indication for HRT?

88a

BADRAWY MRCP Revision

control of vasomotor
symptoms
88b

BADRAWY MRCP Revision

First line investigation for


PE according to current
BTS guidelines?
89a

BADRAWY MRCP Revision

CTPA

89b

BADRAWY MRCP Revision

hypokalaemic metabolic
alkalosis - endocrine
condition?
90a

BADRAWY MRCP Revision

Cushing's syndrome

90b

BADRAWY MRCP Revision

Hemiballism (involuntary,
sudden, jerking
movements) = caused by?
91a

BADRAWY MRCP Revision

damage to the subthalamic


nucleus
91b

BADRAWY MRCP Revision

Acute myeloid leukaemia poor prognosis


92a

BADRAWY MRCP Revision

deletion of chromosome 5
or 7
92b

BADRAWY MRCP Revision

Most common psychiatric


problem in Parkinson's
disease?
93a

BADRAWY MRCP Revision

depression

93b

BADRAWY MRCP Revision

Investigation for Carcinoid

94a

BADRAWY MRCP Revision

Diagnosis: urinary 5-HIAA

94b

BADRAWY MRCP Revision

Adenosine interactions

95a

BADRAWY MRCP Revision

dipyridamole enhances
effect - aminophylline
reduces effect
95b

BADRAWY MRCP Revision

Dystrophia myotonica DM1 CFs


96a

BADRAWY MRCP Revision

DM1 - distal weakness


initially - autosomal
dominant - diabetes dysarthria
96b

BADRAWY MRCP Revision

Restless leg syndrome management


97a

BADRAWY MRCP Revision

dopamine agonists such as


ropinirole
97b

BADRAWY MRCP Revision

Change to steroid dose in


people on long term tx if
intercurrent illness?
98a

BADRAWY MRCP Revision

Double doses

98b

BADRAWY MRCP Revision

Rheumatoid arthritis HLA association?


99a

BADRAWY MRCP Revision

DR4

99b

BADRAWY MRCP Revision

HRT: unopposed oestrogen


increases risk of?
100a

BADRAWY MRCP Revision

endometrial cancer

100b

BADRAWY MRCP Revision

Bosentan - MoA, uses?

101a

BADRAWY MRCP Revision

endothelin-1 receptor
antagonist used if negative
response to acute
vasodilator testing in
pulmonary hypertension
101b

BADRAWY MRCP Revision

Pemphigus vulgaris key


features?
102a

BADRAWY MRCP Revision

Epidermal, desmoglein 3,
involves mucosa, flaccid
non-pruritic blisters,
younger people
102b

BADRAWY MRCP Revision

Head injury followed by


lucid interval?
103a

BADRAWY MRCP Revision

Epidural haematoma

103b

BADRAWY MRCP Revision

Zollinger-Ellison syndrome
- CFs
104a

BADRAWY MRCP Revision

epigastric pain and


diarrhoea
104b

BADRAWY MRCP Revision

Key contraindication to
buproprion?
105a

BADRAWY MRCP Revision

epilepsy

105b

BADRAWY MRCP Revision

Ciclosporin side-effects

106a

BADRAWY MRCP Revision

everything is increased fluid, BP, K+, hair, gums,


glucose
106b

BADRAWY MRCP Revision

Activated protein C
resistance =
107a

BADRAWY MRCP Revision

Factor V Leiden, the most


common inherited
thrombophilia
107b

BADRAWY MRCP Revision

Diabetes diagnosis:

108a

BADRAWY MRCP Revision

fasting > 7.0, random > 11.1


- if asymptomatic need two
readings
HbA1c of 6.5% or greater is
now diagnostic (WHO 2011)
108b

BADRAWY MRCP Revision

investigation of choice for


upper airway compression
109a

BADRAWY MRCP Revision

Flow volume loop

109b

BADRAWY MRCP Revision

Common antibiotic causes


of cholestasis
110a

BADRAWY MRCP Revision

Flucloxacillin + coamoxiclav
110b

BADRAWY MRCP Revision

Ethylene glycol toxicity


management 111a

BADRAWY MRCP Revision

fomepizole. Also ethanol /


haemodialysis
111b

BADRAWY MRCP Revision

Benzodiazepines enhance
the effect of which
neurotransmitter?
112a

BADRAWY MRCP Revision

GABA, the main inhibitory


neurotransmitter
112b

BADRAWY MRCP Revision

Signet ring cells =

113a

BADRAWY MRCP Revision

Gastric adenocarcinoma

113b

BADRAWY MRCP Revision

Screening for
haemochromatosis 114a

BADRAWY MRCP Revision

general population:
transferrin saturation >
ferritin - family members:
HFE genetic testing
114b

BADRAWY MRCP Revision

SSRI + NSAID interaction?

115a

BADRAWY MRCP Revision

GI bleeding risk - give a


PPI
115b

BADRAWY MRCP Revision

Tricyclic overdose - rx

116a

BADRAWY MRCP Revision

give IV bicarbonate

116b

BADRAWY MRCP Revision

ITP - rx

117a

BADRAWY MRCP Revision

give oral prednisolone

117b

BADRAWY MRCP Revision

PHaeochromocytoma -

118a

BADRAWY MRCP Revision

give PHenoxybenzamine
before beta-blockers
118b

BADRAWY MRCP Revision

Exenatide MoA

119a

BADRAWY MRCP Revision

Glucagon-like peptide-1
(GLP-1) mimetic
119b

BADRAWY MRCP Revision

Philadelphia translocation
and prognosis?
120a

BADRAWY MRCP Revision

good prognosis in CML,


poor prognosis in AML +
ALL
120b

BADRAWY MRCP Revision

Absence seizures prognosis

121a

BADRAWY MRCP Revision

good: 90-95% become


seizure free in adolescence
121b

BADRAWY MRCP Revision

Bronchiectasis: most
common organism?
122a

BADRAWY MRCP Revision

Haemophilus influenzae

122b

BADRAWY MRCP Revision

Cyclophosphamide SE:

123a

BADRAWY MRCP Revision

haemorrhagic cystitis prevent with mesna


123b

BADRAWY MRCP Revision

Genital ulcers - painful:

124a

BADRAWY MRCP Revision

herpes >> chancroid

124b

BADRAWY MRCP Revision

CT head showing temporal


lobe changes - think what?
125a

BADRAWY MRCP Revision

herpes simplex
encephalitis,temporoparietal
attentuation subacute onset i.e. Several
days.
125b

BADRAWY MRCP Revision

most common cause of


sudden cardiac death in the
young
126a

BADRAWY MRCP Revision

HOCM

126b

BADRAWY MRCP Revision

U waves on ECG

127a

BADRAWY MRCP Revision

Hypokalaemia -

127b

BADRAWY MRCP Revision

Liddle's syndrome:

128a

BADRAWY MRCP Revision

hypokalaemia +
hypertension
128b

BADRAWY MRCP Revision

Hashimoto's thyroiditis key


features?
129a

BADRAWY MRCP Revision

hypothyroidism + goitre +
anti-TPO
129b

BADRAWY MRCP Revision

Asymmetrical symptoms in
PD suggest what cause?
130a

BADRAWY MRCP Revision

Idiopathic Parkinson's

130b

BADRAWY MRCP Revision

NSTEMI/unstable angina
Rx. 6 month mortality risk
>1.5% vs 6m risk >3%
131a

BADRAWY MRCP Revision

if > 1.5% clopidogrel for 12


months - if > 3%
angiography within 96
hours
131b

BADRAWY MRCP Revision

Primary biliary cirrhosis the M rule mnemonic?


132a

BADRAWY MRCP Revision

IgM - anti-Mitochondrial
antibodies, M2 subtype Middle aged females
132b

BADRAWY MRCP Revision

What is rheumatoid factor?

133a

BADRAWY MRCP Revision

IgM antibody against IgG

133b

BADRAWY MRCP Revision

CLL - investigation of
choice?
134a

BADRAWY MRCP Revision

immunophenotyping

134b

BADRAWY MRCP Revision

Nicotinic acid MoA

135a

BADRAWY MRCP Revision

increases HDL levels

135b

BADRAWY MRCP Revision

Essential tremor:
inheritance, aggravants /
relievants
136a

BADRAWY MRCP Revision

Inheritance: AD
Aggravants: Arms
outstretched
Relievants: Alcohol,
propanolol
136b

BADRAWY MRCP Revision

Ciclosporin + tacrolimus MOA:


137a

BADRAWY MRCP Revision

inhibit calcineurin thus


decreasing IL-2
137b

BADRAWY MRCP Revision

Statins - MoA?

138a

BADRAWY MRCP Revision

inhibit HMG-CoA
reductase, the rate-limiting
enzyme in hepatic
cholesterol synthesis
138b

BADRAWY MRCP Revision

Bisphosphonates MoA

139a

BADRAWY MRCP Revision

inhibit osteoclasts,prevent
steroid incduced
osteoperosis
(vitamin D also).
139b

BADRAWY MRCP Revision

Clopidogrel MoA:

140a

BADRAWY MRCP Revision

inhibits ADP binding to


platelet receptors
140b

BADRAWY MRCP Revision

Dipyridamole - MoA

141a

BADRAWY MRCP Revision

inhibits phosphodiesterase

141b

BADRAWY MRCP Revision

Digoxin - MoA

142a

BADRAWY MRCP Revision

inhibits the Na+/K+


ATPase pump
142b

BADRAWY MRCP Revision

Isoniazid SEs:

143a

BADRAWY MRCP Revision

inhibits the P450 system,


causes peripheral
neuropathy
143b

BADRAWY MRCP Revision

Allopurinol MoA

144a

BADRAWY MRCP Revision

inhibits xanthine oxidase

144b

BADRAWY MRCP Revision

Symptom control in nonCF bronchiectasis?


145a

BADRAWY MRCP Revision

inspiratory muscle training


+ postural drainage
145b

BADRAWY MRCP Revision

Complete heart block


following an ANterior MI ?pacing
146a

BADRAWY MRCP Revision

is AN indication for pacing,


unlike with an inferior MI
146b

BADRAWY MRCP Revision

Streptococcus pneumoniae

147a

BADRAWY MRCP Revision

is associated with cold


sores
147b

BADRAWY MRCP Revision

Streptococcus bovis
endocarditis
148a

BADRAWY MRCP Revision

is associated with
colorectal cancer
148b

BADRAWY MRCP Revision

Legionella pneumophilia

149a

BADRAWY MRCP Revision

is best diagnosed by the


urinary antigen test
149b

BADRAWY MRCP Revision

Complete heart block


following an INferior MI - ?
pacing
150a

BADRAWY MRCP Revision

Is Not an indication for


pacing, unlike with an
anterior MI
150b

BADRAWY MRCP Revision

Most common cause of


occupational asthma?
151a

BADRAWY MRCP Revision

Isocyanates

151b

BADRAWY MRCP Revision

Lichen sclerosus:

152a

BADRAWY MRCP Revision

itchy white spots typically


seen on the vulva of elderly
women
152b

BADRAWY MRCP Revision

Polycythaemia rubra vera genetic cause?


153a

BADRAWY MRCP Revision

JAK2 mutation

153b

BADRAWY MRCP Revision

Hypertension - step 4 rx?

154a

BADRAWY MRCP Revision

K+ < 4.5 then


spironolactone - K+ > 4.5
then higher-dose thiazidelike diuretic
154b

BADRAWY MRCP Revision

Pneumonia in an alcoholic
- pathogen?
155a

BADRAWY MRCP Revision

Klebsiella

155b

BADRAWY MRCP Revision

BTS COPD: breathless


despite PRN inhalers, and
FEV1 < 50%
156a

BADRAWY MRCP Revision

LABA + ICS or LAMA

156b

BADRAWY MRCP Revision

BTS COPD: breathless


despite PRN inhalers, and
FEV1 > 50%:
157a

BADRAWY MRCP Revision

LABA or LAMA

157b

BADRAWY MRCP Revision

Polymorphic eruption of
pregnancy - CFs?
158a

BADRAWY MRCP Revision

Last trimester, may see


vesicles, but no blistering
158b

BADRAWY MRCP Revision

Cerebellar signs,
contralateral sensory loss &
ipsilateral Horner's =
159a

BADRAWY MRCP Revision

Lateral medullary
syndrome - PICA lesion 159b

BADRAWY MRCP Revision

Mucocutaneous ulceration
following travel - key
differential?
160a

BADRAWY MRCP Revision

Leishmania brasiliensis

160b

BADRAWY MRCP Revision

Most common presenting


symptom in myelofibrosis?
161a

BADRAWY MRCP Revision

lethargy

161b

BADRAWY MRCP Revision

Safest TCA in overdosage?

162a

BADRAWY MRCP Revision

Lofepramine

162b

BADRAWY MRCP Revision

Second heart sound (S2) loud, soft, fixed split,


reversed split?
163a

BADRAWY MRCP Revision

loud: hypertension - soft:


AS - fixed split: ASD reversed split: LBBB
163b

BADRAWY MRCP Revision

ESR in polycythaemia
rubra vera
164a

BADRAWY MRCP Revision

low

164b

BADRAWY MRCP Revision

Oxygen dissociation curve shifts Left?


165a

BADRAWY MRCP Revision

Lower oxygen delivery Lower acidity, temp, 2-3


DPG - also HbF,
carboxy/methaemoglobin 165b

BADRAWY MRCP Revision

Most common lung cancer


type in non-smokers?
166a

BADRAWY MRCP Revision

Lung adenocarcinoma peripheral lesion


166b

BADRAWY MRCP Revision

Gallop rhythm (S3) is an


early sign of?
167a

BADRAWY MRCP Revision

LVF

167b

BADRAWY MRCP Revision

Hodgkin's lymphoma - best


prognosis =
168a

BADRAWY MRCP Revision

lymphocyte predominant

168b

BADRAWY MRCP Revision

Patients with Sjogren's


syndrome have an
increased risk of which
malignancy?
169a

BADRAWY MRCP Revision

lymphoid malignancies

169b

BADRAWY MRCP Revision

Rx for Mycoplasma
pneumonia
170a

BADRAWY MRCP Revision

Macrolides. If allergic
=doxycycline
170b

BADRAWY MRCP Revision

Eclampsia - first-line
treatment
171a

BADRAWY MRCP Revision

magnesium sulphate

171b

BADRAWY MRCP Revision

Sarcoidosis prognosis?

172a

BADRAWY MRCP Revision

Majority of patients get


better without treatment
172b

BADRAWY MRCP Revision

PTH level in primary


hyperparathyroidism
173a

BADRAWY MRCP Revision

may be normal

173b

BADRAWY MRCP Revision

TNF-#alpha# inhibitors

174a

BADRAWY MRCP Revision

may reactivate TB

174b

BADRAWY MRCP Revision

Choosing prosthetic heart


valves
175a

BADRAWY MRCP Revision

mechanical valves last


longer and tend to be given
to younger patients
175b

BADRAWY MRCP Revision

Prolactinoma management
-medical or surgical?
176a

BADRAWY MRCP Revision

medical therapy is almost


always first-line
176b

BADRAWY MRCP Revision

Autosomal recessive
conditions tend to be ??
with what exceptions?
177a

BADRAWY MRCP Revision

Metabolic. Exception =
inherited ataxias
177b

BADRAWY MRCP Revision

Acne rosacea treatment: -

178a

BADRAWY MRCP Revision

mild/moderate: topical
metronidazole severe/resistant: oral
tetracycline
178b

BADRAWY MRCP Revision

Kearns-Sayre syndrome -

179a

BADRAWY MRCP Revision

mitochondrial inheritance onset < 20-years-old external ophthalmoplegia retinitis pigmentosa


179b

BADRAWY MRCP Revision

Common topical steroids


and their potency?
180a

BADRAWY MRCP Revision

moderate: Clobetasone
butyrate 0.05% - potent:
Betamethasone valerate 0.1%
- very potent: Clobetasol
propionate 0.05%
180b

BADRAWY MRCP Revision

Magnesium sulphate monitoring


181a

BADRAWY MRCP Revision

monitor reflexes +
respiratory rate
181b

BADRAWY MRCP Revision

Cetuximab - MoA?

182a

BADRAWY MRCP Revision

monoclonal antibody
against the epidermal
growth factor receptor
182b

BADRAWY MRCP Revision

Trastuzumab (Herceptin) -

183a

BADRAWY MRCP Revision

monoclonal antibody that


acts on the HER2/neu
receptor
183b

BADRAWY MRCP Revision

Anorexia features -

184a

BADRAWY MRCP Revision

most things low - G's and


C's raised: growth
hormone, glucose, salivary
glands, cortisol,
cholesterol, carotinaemia
184b

BADRAWY MRCP Revision

Rises first following MI?

185a

BADRAWY MRCP Revision

Myoglobin

185b

BADRAWY MRCP Revision

Hypercholesterolaemia
rather than
hypertriglyceridaemia:
186a

BADRAWY MRCP Revision

nephrotic syndrome,
cholestasis,
hypothyroidism
186b

BADRAWY MRCP Revision

Signs suggesting TTP


rather than HUS?
187a

BADRAWY MRCP Revision

Neuro signs and purpura


point towards TTP
187b

BADRAWY MRCP Revision

Motor neuron disease treatment:


188a

BADRAWY MRCP Revision

NIV is better than riluzole

188b

BADRAWY MRCP Revision

AF treatment: young man,


no TIA or risk factors,
189a

BADRAWY MRCP Revision

no treatment is now
preferred to aspirin
189b

BADRAWY MRCP Revision

Hodgkin's lymphoma most common type =


190a

BADRAWY MRCP Revision

nodular sclerosing

190b

BADRAWY MRCP Revision

Renal tubular acidosis anion gap?


191a

BADRAWY MRCP Revision

normal anion gap

191b

BADRAWY MRCP Revision

Urinary incontinence + gait


abnormality + dementia.
Diagnosis?
192a

BADRAWY MRCP Revision

normal pressure
hydrocephalus
192b

BADRAWY MRCP Revision

Rx metastatic bone pain

193a

BADRAWY MRCP Revision

NSAIDs, bisphosphonates
or radiotherapy
193b

BADRAWY MRCP Revision

Acromegaly diagnosis?

194a

BADRAWY MRCP Revision

oral glucose tolerance with


growth hormone
measurements
194b

BADRAWY MRCP Revision

Cushing's syndrome - best


test to diagnose?
195a

BADRAWY MRCP Revision

overnight dexamethasone
suppression test
195b

BADRAWY MRCP Revision

Drug metabolism - phase I


components?
196a

BADRAWY MRCP Revision

oxidation, reduction,
hydrolysis
196b

BADRAWY MRCP Revision

Antiphospholipid
syndrome: APPT, PLTs
197a

BADRAWY MRCP Revision

Paradoxically prolonged
APTT + low platelets
197b

BADRAWY MRCP Revision

Progressive supranuclear
palsy CFs?
198a

BADRAWY MRCP Revision

Absent voluntary downward


gaze, normal dolls eye . i.e.
Occulomotor nuclei intact,
supranuclear Pathology.
parkinsonism
198b

BADRAWY MRCP Revision

SSRI with high incidence of


discontinuation symptoms?
199a

BADRAWY MRCP Revision

Paroxetine

199b

BADRAWY MRCP Revision

Collapsing pulse - which


congenital heart defect?
200a

BADRAWY MRCP Revision

Patent ductus arteriosus -

200b

BADRAWY MRCP Revision

Vincristine - important SE?

201a

BADRAWY MRCP Revision

peripheral neuropathy

201b

BADRAWY MRCP Revision

Drugs with zero-order


(saturation) kinetics 202a

BADRAWY MRCP Revision

phenytoin - alcohol

202b

BADRAWY MRCP Revision

Causes of gingival
hyperplasia?
203a

BADRAWY MRCP Revision

phenytoin, ciclosporin,
calcium channel blockers
and AML
203b

BADRAWY MRCP Revision

TTP first-line Rx?

204a

BADRAWY MRCP Revision

Plasma exchange

204b

BADRAWY MRCP Revision

Painful third nerve palsy key differential?


205a

BADRAWY MRCP Revision

posterior communicating
artery aneurysm
205b

BADRAWY MRCP Revision

Horner's syndrome anhydrosis absent =


206a

BADRAWY MRCP Revision

post-ganglionic lesion:
carotid artery
206b

BADRAWY MRCP Revision

Rx Minimal change
glomerulonephritis?
207a

BADRAWY MRCP Revision

prednisolone

207b

BADRAWY MRCP Revision

Horner's syndrome anhydrosis of just face =


208a

BADRAWY MRCP Revision

pre-ganglionic lesion:
Pancoast's, cervical rib
208b

BADRAWY MRCP Revision

Causes of raised prolactin?

209a

BADRAWY MRCP Revision

pregnancy - prolactinoma physiological - polycystic ovarian


syndrome - primary
hypothyroidism phenothiazines,
metoclopramide, domperidone
209b

BADRAWY MRCP Revision

Taxanes (e.g. Docetaxel)


MoA?
210a

BADRAWY MRCP Revision

prevent microtubule
disassembly
210b

BADRAWY MRCP Revision

Infective endocarditis strongest risk factor


211a

BADRAWY MRCP Revision

previous episode of
infective endocarditis
211b

BADRAWY MRCP Revision

Ptosis + dilated pupil vs


Ptosis + constricted pupil
212a

BADRAWY MRCP Revision

Ptosis + dilated pupil = 3rd


nerve palsy; Ptosis +
constricted pupil =
Horner's
212b

BADRAWY MRCP Revision

Lichen - planus:

213a

BADRAWY MRCP Revision

purple, pruritic, papular,


polygonal rash on flexor
surfaces. Wickham's striae
over surface. Oral
involvement common
213b

BADRAWY MRCP Revision

Oxygen dissociation curve shifts Right?


214a

BADRAWY MRCP Revision

Raised oxygen delivery Raised acidity, temp, 2-3


DPG
214b

BADRAWY MRCP Revision

HbA1C - when to recheck


after change in therapy?
215a

BADRAWY MRCP Revision

recheck after 2-3 months

215b

BADRAWY MRCP Revision

Inferior MI -

216a

BADRAWY MRCP Revision

right coronary artery lesion

216b

BADRAWY MRCP Revision

Farmers lung pathogen

217a

BADRAWY MRCP Revision

Saccharopolyspora
rectivirgula
217b

BADRAWY MRCP Revision

Erythema nodosum is
associated with a good
prognosis in what systemic
condition?
218a

BADRAWY MRCP Revision

sarcoidosis

218b

BADRAWY MRCP Revision

Combined B- and T-cell


disorders
219a

BADRAWY MRCP Revision

SCID WAS ataxic (SCID,


Wiskott-Aldrich syndrome,
ataxic telangiectasia)
219b

BADRAWY MRCP Revision

Pulsus alternans?

220a

BADRAWY MRCP Revision

seen in left ventricular


failure
220b

BADRAWY MRCP Revision

HOCM - poor prognostic


factor on echo =
221a

BADRAWY MRCP Revision

septal wall thickness of >


3cm
221b

BADRAWY MRCP Revision

Detecting occupational
asthma?
222a

BADRAWY MRCP Revision

Serial peak flow


measurements at work and
at home
222b

BADRAWY MRCP Revision

Mycoplasma diagnosis

223a

BADRAWY MRCP Revision

Serology

223b

BADRAWY MRCP Revision

Dx Addison's disease

224a

BADRAWY MRCP Revision

short synacthen test

224b

BADRAWY MRCP Revision

Epilepsy medication: firstline - generalised seizure:


225a

BADRAWY MRCP Revision

sodium valproate -

225b

BADRAWY MRCP Revision

Syringomyelia - CFs?

226a

BADRAWY MRCP Revision

spinothalamic sensory loss


(pain and temperature)
226b

BADRAWY MRCP Revision

Asthma diagnosis - first


line investigation in
intermediate probability?
227a

BADRAWY MRCP Revision

Spirometry

227b

BADRAWY MRCP Revision

Paraneoplastic features of
lung cancer - squamous cell
vs small cell?
228a

BADRAWY MRCP Revision

squamous cell: PTHrp,


clubbing, HPOA - small
cell: ADH, ACTH, LambertEaton syndrome
228b

BADRAWY MRCP Revision

Pneumonia following
influenza - pathogen?
229a

BADRAWY MRCP Revision

Staphylococcus aureus
pneumonia
229b

BADRAWY MRCP Revision

Most common cause of


endocarditis if < 2 months
post valve surgery
230a

BADRAWY MRCP Revision

Staphylococcus
epidermidis
230b

BADRAWY MRCP Revision

Asthma diagnosis - first


line investigation in high
probability?
231a

BADRAWY MRCP Revision

Start treatment

231b

BADRAWY MRCP Revision

Infective endocarditis good prognosis


232a

BADRAWY MRCP Revision

streptococcal infection

232b

BADRAWY MRCP Revision

Most common cause of


endocarditis
233a

BADRAWY MRCP Revision

Streptococcus viridans

233b

BADRAWY MRCP Revision

Antipsychotics in the
elderly -> risk of?
234a

BADRAWY MRCP Revision

stroke and VTE

234b

BADRAWY MRCP Revision

Autosomal dominant
conditions tend to be ?? with what exceptions?
235a

BADRAWY MRCP Revision

Structural. Exceptions =
hyperlipidaemia type II,
hypokalaemic periodic
paralysis
235b

BADRAWY MRCP Revision

Cluster headache - acute


treatment
236a

BADRAWY MRCP Revision

subcutaneous sumatriptan
+ 100% O2
236b

BADRAWY MRCP Revision

Bullous pemphigoid key


features?
237a

BADRAWY MRCP Revision

Subepidermal,
hemidesmosomal BP
antigens, rarely involves
mucosa, tense pruritic
blisters, older people
237b

BADRAWY MRCP Revision

Diagnosing insulinoma?

238a

BADRAWY MRCP Revision

supervised prolonged
fasting
238b

BADRAWY MRCP Revision

Cryptosporidium diarrhoea
Rx
239a

BADRAWY MRCP Revision

Supportive therapy

239b

BADRAWY MRCP Revision

Contraindications to lung
cancer surgery
240a

BADRAWY MRCP Revision

SVC obstruction, FEV < 1.5,


MALIGNANT pleural
effusion, and vocal cord
paralysis
240b

BADRAWY MRCP Revision

Reason for ^sweating in


acromegaly
241a

BADRAWY MRCP Revision

sweat gland hypertrophy

241b

BADRAWY MRCP Revision

Alcohol withdrawal time to


symptoms/signs
242a

BADRAWY MRCP Revision

symptoms: 6-12 hours seizures: 36 hours delirium tremens: 72 hours


242b

BADRAWY MRCP Revision

Genital ulcers - painless:

243a

BADRAWY MRCP Revision

syphilis >
lymphogranuloma
venereum + granuloma
inguinale
243b

BADRAWY MRCP Revision

Philadelphia translocation?

244a

BADRAWY MRCP Revision

t(9;22)

244b

BADRAWY MRCP Revision

Congenital heart disease cyanotic - most common


cause:
245a

BADRAWY MRCP Revision

TGA most common at


birth, Fallot's most
common overall 245b

BADRAWY MRCP Revision

Melanoma: single most


important prognostic factor
246a

BADRAWY MRCP Revision

the invasion depth of the


tumour
246b

BADRAWY MRCP Revision

Diuretic cause of
hypercalcaemia?
247a

BADRAWY MRCP Revision

Thiazides

247b

BADRAWY MRCP Revision

Disproportionate
microcytic anaemia think?
248a

BADRAWY MRCP Revision

think beta-thalassaemia
trait
248b

BADRAWY MRCP Revision

Hashimoto's thyroiditis is
associated with which
malignancy?
249a

BADRAWY MRCP Revision

thyroid lymphoma

249b

BADRAWY MRCP Revision

Impetigo - rx

250a

BADRAWY MRCP Revision

topical fusidic acid --> oral


flucloxacillin / topical
retapamulin
250b

BADRAWY MRCP Revision

Chlamydia - treatment

251a

BADRAWY MRCP Revision

treat with azithromycin or


doxycycline
251b

BADRAWY MRCP Revision

JVP: giant v waves

252a

BADRAWY MRCP Revision

tricuspid regurgitation

252b

BADRAWY MRCP Revision

Associations in
mesangiocapillary /
membranoproliferative
GN. Type 1 vs Type 2
253a

BADRAWY MRCP Revision

type 1: cryoglobulinaemia,
hepatitis C - type 2: partial
lipodystrophy
253b

BADRAWY MRCP Revision

Aortic dissection - Type A

254a

BADRAWY MRCP Revision

type A - ascending aorta control BP(IV labetalol) +


surgery
254b

BADRAWY MRCP Revision

Aortic dissection - Type B

255a

BADRAWY MRCP Revision

type B - descending aorta control BP(IV labetalol), no


surgery
255b

BADRAWY MRCP Revision

Diagnosing systemic
mastocytosis?
256a

BADRAWY MRCP Revision

Urinary histamine

256b

BADRAWY MRCP Revision

Vigabatrin - important SE?

257a

BADRAWY MRCP Revision

V for Vigabatrin - V for


Visual field defects
257b

BADRAWY MRCP Revision

Ventricular tachycardia which antiarrhythmic is


contraindicated?
258a

BADRAWY MRCP Revision

verapamil

258b

BADRAWY MRCP Revision

macrophages containing
Periodic acid-Schiff (PAS)
granules
259a

BADRAWY MRCP Revision

Whipple's disease jejunal


biopsy
259b

BADRAWY MRCP Revision

PCI - biggest RF for stent


thrombosis?
260a

BADRAWY MRCP Revision

withdrawal of antiplatelets

260b

BADRAWY MRCP Revision

Alport's syndrome
inheritance
261a

BADRAWY MRCP Revision

X-linked dominant (in the


majority)
261b

BADRAWY MRCP Revision

Keloid scars - more


common in who and what
body part?
262a

BADRAWY MRCP Revision

young, black, male adults


on the sternum
262b

BADRAWY MRCP Revision

Ankylosing spondylitis: CFs

263a

BADRAWY MRCP Revision

Features - the 'A's


Apical fibrosis (CXR)
Anterior uveitis
Aortic regurgitation
Achilles tendonitis
AV node block
Amyloidosis
And cauda equina syndrome

263b

BADRAWY MRCP Revision

Septic arthritis - most


common organism?
264a

BADRAWY MRCP Revision

Staphylococcus aureus

264b

BADRAWY MRCP Revision

Low levels of which type of


complement are associated
with SLE?
265a

BADRAWY MRCP Revision

C3, C4a and C4b

265b

BADRAWY MRCP Revision

What should you check


before starting
azathioprine?
266a

BADRAWY MRCP Revision

Check thiopurine
methyltransferase
deficiency (TPMT) before
treatment
266b

BADRAWY MRCP Revision

When to start allopurinol


in gout?
267a

BADRAWY MRCP Revision

>= 2 attacks in 12 month


period.
267b

BADRAWY MRCP Revision

Which cytokine is most


important in
pathophysiology of
rheumatoid arthritis?
268a

BADRAWY MRCP Revision

TNF

268b

BADRAWY MRCP Revision

Nitric oxide - key effects

269a

BADRAWY MRCP Revision

Vasodilation - mainly
venodilation
Inhibits platelet
aggregation
269b

BADRAWY MRCP Revision

Superiority vs equivalence
vs non-inferiority. What
sample sizes?
270a

BADRAWY MRCP Revision

Superiority trial --> large


sample size needed.
270b

BADRAWY MRCP Revision

Clotting factors affected by


warfarin?
271a

BADRAWY MRCP Revision

Mnemonic = 1972 (Simon)


- 10, 9, 7 and 2.
271b

BADRAWY MRCP Revision

Adrenal cortex - what part


releases what?
272a

BADRAWY MRCP Revision

Mnemonic GFR - ACD


1) Glomerulosa (outer):
Aldosterone
2) Fasciculata (middle): Cortisol
3) Reticularis (on inside): DHEA
and androgens
272b

BADRAWY MRCP Revision

Obese T2DM with


abnormal LFTs - think of
what disease?
273a

BADRAWY MRCP Revision

non-alcoholic fatty liver


disease
273b

BADRAWY MRCP Revision

EBV-associated
malignancies
274a

BADRAWY MRCP Revision

Burkitt's lymphoma
Hodgkin's lymphoma
nasopharyngeal carcinoma
HIV-associated central nervous
system lymphomas
Hairy leukoplakia (non malignant).
274b

BADRAWY MRCP Revision

Associations between
hypermetropia/myopia and
glaucoma?
275a

BADRAWY MRCP Revision

Acute angle closure glaucoma


is associated with
hypermetropia, where as
primary open-angle glaucoma
is associated with myopia
275b

BADRAWY MRCP Revision

Antiphospholipid
syndrome: key triad of
features
276a

BADRAWY MRCP Revision

arterial/venous
thrombosis, miscarriage,
livedo reticularis
276b

BADRAWY MRCP Revision

Types of cells seen in CLL?

277a

BADRAWY MRCP Revision

CLL is caused by a
monoclonal proliferation of
B-cell lymphocytes
277b

BADRAWY MRCP Revision

Atrial natriuretic peptide effect on vessels?


278a

BADRAWY MRCP Revision

Atrial natriuretic peptide powerful vasodilator


278b

BADRAWY MRCP Revision

Most common cause of


primary
hyperaldosteronism
279a

BADRAWY MRCP Revision

Bilateral idiopathic adrenal


hyperplasia is the most
common cause of primary
hyperaldosteronism
279b

BADRAWY MRCP Revision

Obesity - NICE bariatric


referral cut offs
280a

BADRAWY MRCP Revision

NICE bariatric referral cutoffs


with risk factors (T2DM, BP
etc): > 35 kg/m^2
no risk factors: > 40 kg/m^2
280b

BADRAWY MRCP Revision

CT most commonly
associated with PBC
281a

BADRAWY MRCP Revision

Sjogren's syndrome

281b

BADRAWY MRCP Revision

How names of ART drugs


relate to function
282a

BADRAWY MRCP Revision

HIV drugs, rule of thumb:


NRTIs end in 'ine'
Pis: end in 'vir'
NNRTIs: nevirapine,
efavirenz
282b

BADRAWY MRCP Revision

Interpreting the ACR


results
283a

BADRAWY MRCP Revision

in non-diabetics an ACR greater than 30


mg/mmol is considered clinically
significant proteinuria
in diabetics microalbuminuria (ACR
greater than 2.5 mg/mmol in men and
ACR greater than 3.5 mg/mmol in women)
is considered clinically significant
283b

BADRAWY MRCP Revision

Which antiepileptic is safe


in breast feeding?
284a

BADRAWY MRCP Revision

Breast feeding is acceptable


with nearly all antiepileptic drugs
284b

BADRAWY MRCP Revision

ATN or prerenal uraemia?

285a

BADRAWY MRCP Revision

In prerenal uraemia think


of the kidneys holding on
to sodium to preserve
volume
285b

BADRAWY MRCP Revision

Renal stones on x-ray

286a

BADRAWY MRCP Revision

cystine stones: semiopaque


urate + xanthine stones:
radio-lucent
286b

BADRAWY MRCP Revision

Isoretinoin adverse effects?

287a

BADRAWY MRCP Revision

teratogenicity - females MUST be


taking contraception
low mood
dry eyes and lips
raised triglycerides
hair thinning
nose bleeds
287b

BADRAWY MRCP Revision

An important and common


interaction with statins?
288a

BADRAWY MRCP Revision

Statins +
erythromycin/clarithromycin
- an important and common
interaction
288b

BADRAWY MRCP Revision

Low CSF glucose but viral


aetiology in meningitis?
289a

BADRAWY MRCP Revision

Mumps meningitis is
associated with a low
glucose in up to a third of
patients
289b

BADRAWY MRCP Revision

Type of bladder cancer


association with
schistosomiasis
290a

BADRAWY MRCP Revision

SchistoSomiaSiS is a risk
factor for SquamouS cell
bladder cancer
290b

BADRAWY MRCP Revision

%tage of people with Hep C


developing cirrhosis?
291a

BADRAWY MRCP Revision

Liver cirrhosis will develop


in around 20-30% of
patients over 20-30 years
291b

BADRAWY MRCP Revision

Rash on buttocks

292a

BADRAWY MRCP Revision

Dermatitis herpetiformis
(coeliac dx).
292b

BADRAWY MRCP Revision

Obese woman,
papilledema/headache
293a

BADRAWY MRCP Revision

Benign Intercanial
Hypertention.
293b

BADRAWY MRCP Revision

Drug induced pneumonitis

294a

BADRAWY MRCP Revision

methotrexate or
amiodarone.
294b

BADRAWY MRCP Revision

foreign travel, macpap


rash/flu like illnes
295a

BADRAWY MRCP Revision

HIV acute.

295b

BADRAWY MRCP Revision

Splenectomy

296a

BADRAWY MRCP Revision

need pneumococcal vaccine


AT LEAST 2 weeks pre-op
and for life.
296b

BADRAWY MRCP Revision

Primary
hrperparathyroidism
297a

BADRAWY MRCP Revision

high Ca, normal/low PO4,


normal/high PTH (in
elderly).
297b

BADRAWY MRCP Revision

Middle aged man with


KNEE arthritis
298a

BADRAWY MRCP Revision

gonococcal sepsis (older


people Staph).
298b

BADRAWY MRCP Revision

Sarcoidosis, erythema
nodosum, arthropathy
299a

BADRAWY MRCP Revision

Loffgrens syndrome
benign, no Rx needed or
NSAIDs
299b

BADRAWY MRCP Revision

TREMOR postural, slow


progression,titubation,
300a

BADRAWY MRCP Revision

benign essential TREMOR


AutDom.
300b

BADRAWY MRCP Revision

Contraindications lung
Surgery
301a

BADRAWY MRCP Revision

FEV dec bp 130/90, Ace


inhibitors (if proteinuria
analgesic induced
headache.
301b

BADRAWY MRCP Revision

1.5 cm difference btwn


kidneys
302a

BADRAWY MRCP Revision

Renal artery stenosis


Magnetic resonance
angiogram.
302b

BADRAWY MRCP Revision

Temporal tenderness

303a

BADRAWY MRCP Revision

temporal arteritis
steroids > 90% ischemic
neuropathy, 10%
retinal art occlusion.
303b

BADRAWY MRCP Revision

cluster headache.

304a

BADRAWY MRCP Revision

Severe retroorbital, daily


headache, lacrimation
304b

BADRAWY MRCP Revision

Diagnosis of polyuria

305a

BADRAWY MRCP Revision

water deprivation test, then


DDAVP
305b

BADRAWY MRCP Revision

Causes of villous atrophy

306a

BADRAWY MRCP Revision

coeliac (lymphocytic
infiltrate), Whipples , dec Ig,
lymphoma, trop sprue (Rx
tetracycline).
306b

BADRAWY MRCP Revision

Hepatitis B with general


deterioration
307a

BADRAWY MRCP Revision

hepaocellular carcinoma

307b

BADRAWY MRCP Revision

Albumin normal, total


protein high
308a

BADRAWY MRCP Revision

myeloma (hypercalcemia,
electrophoresis).
308b

BADRAWY MRCP Revision

HBsAg positive, HB DNA


not detectable
309a

BADRAWY MRCP Revision

chornic carirer

309b

BADRAWY MRCP Revision

Aortic Stenosis

310a

BADRAWY MRCP Revision

s2 paradoxical split, length


proportional to severity
310b

BADRAWY MRCP Revision

Loud S1

311a

BADRAWY MRCP Revision

MS, hyperdynamic, short


PR
311b

BADRAWY MRCP Revision

Soft S1

312a

BADRAWY MRCP Revision

immobile MS, MR.

312b

BADRAWY MRCP Revision

Loud S2

313a

BADRAWY MRCP Revision

hypertension, AS

313b

BADRAWY MRCP Revision

Fixed split

314a

BADRAWY MRCP Revision

ASD

314b

BADRAWY MRCP Revision

Opening snap

315a

BADRAWY MRCP Revision

MOBILE MS, severe near


S2
315b

BADRAWY MRCP Revision

HOCM/MVP

316a

BADRAWY MRCP Revision

inc by standing,valsalva,
dec by squating (# all
others)
316b

BADRAWY MRCP Revision

HOCM

317a

BADRAWY MRCP Revision

Sudden death athlete, FH,


Rx. Amiodarone, ICD
317b

BADRAWY MRCP Revision

Guillan Barre syndrome

318a

BADRAWY MRCP Revision

check VITAL CAPACITY.

318b

BADRAWY MRCP Revision

Horners

319a

BADRAWY MRCP Revision

sweating lost in upper face


only - lesion proximal to
common carotid artery.
319b

BADRAWY MRCP Revision

Internuclear
opthalmoplegia
320a

BADRAWY MRCP Revision

medial longitudinal
fasciculus connects CN
nucleus 3-4.
320b

BADRAWY MRCP Revision

Perinauds syndrome

321a

BADRAWY MRCP Revision

dorsal midbrain syndrome,


damaged midrain and superior
colliculus: impaired upgaze (cf
PSNP), lid retraction, convergence
preserved. Causes: pineal tumor,
stroke, hydrocephalus, MS.
321b

BADRAWY MRCP Revision

Acute red eye

322a

BADRAWY MRCP Revision

acute closed angle


glaucoma >> less common
(ant uveitis, scleritis,
episcleritis, subconjuntival
hemmorrhage).
322b

BADRAWY MRCP Revision

Sweats and weight gain

323a

BADRAWY MRCP Revision

insulinoma.

323b

BADRAWY MRCP Revision

Diagnostic test for asthma

324a

BADRAWY MRCP Revision

morning dip in PEFR


>20%.
324b

BADRAWY MRCP Revision

Causes of SIADH

325a

BADRAWY MRCP Revision

chest/cerebral/pancreas Pathology
, porphyria, malignancy, Drugs
(carbamazepine, chlorpropamide,
clofibrate, atipsychotics, NSAIDs,
rifampicin, opiates)
325b

BADRAWY MRCP Revision

Causes of central DI

326a

BADRAWY MRCP Revision

tumor, infiltration, trauma

326b

BADRAWY MRCP Revision

Causes of Nephrogenic DI

327a

BADRAWY MRCP Revision

Lithium, amphoteracin,
domeclocycline, prologed
hypercalcemia/hypornatremia,
FAMILIAL X linked type
327b

BADRAWY MRCP Revision

Returned from airline


flight, TIA
328a

BADRAWY MRCP Revision

paradoxical embolus do
TEE.
328b

BADRAWY MRCP Revision

Alcoholic, given glucose


develops nystagmus
329a

BADRAWY MRCP Revision

B1 deficiency (wernickes).

329b

BADRAWY MRCP Revision

Mono-artropathy with
thiazide
330a

BADRAWY MRCP Revision

gout (neg birefringence).


NO ALLOPURINOL for
acute.
330b

BADRAWY MRCP Revision

MC Cause of gout

331a

BADRAWY MRCP Revision

dec urinary excretion

331b

BADRAWY MRCP Revision

Painful 3rd nerve palsy

332a

BADRAWY MRCP Revision

posterior communicating
artery aneurysm till proven
otherwise
332b

BADRAWY MRCP Revision

Late complication of
scleroderma
333a

BADRAWY MRCP Revision

pulmonary hypertention
fibrosis
333b

BADRAWY MRCP Revision

Mouth/genital ulcers and


oligarthritis
334a

BADRAWY MRCP Revision

behcets (also eye /SKIN


lesions, DVT)
334b

BADRAWY MRCP Revision

Cavernous sinus syndrome

335a

BADRAWY MRCP Revision

3rd nerve palsy, proptosis,


periorbital swelling, conj
injection
335b

BADRAWY MRCP Revision

Asymetric parkinsons

336a

BADRAWY MRCP Revision

likely to be idiopathic

336b

BADRAWY MRCP Revision

Obese, NIDDM with


abnormal LFT's
337a

BADRAWY MRCP Revision

NASH

337b

BADRAWY MRCP Revision

Ipsilateral ataxia, Horners,


contralateral loss
pain/temp
338a

BADRAWY MRCP Revision

PICA stroke (lateral


medulary syndrome of
Wallenburg)
338b

BADRAWY MRCP Revision

Distal, asymetric
arthropathy
339a

BADRAWY MRCP Revision

PSORIASIS

339b

BADRAWY MRCP Revision

Episodic headache with


tachycardia
340a

BADRAWY MRCP Revision

Pheochromocytoma

340b

BADRAWY MRCP Revision

Very raised WCC

341a

BADRAWY MRCP Revision

ALWAYS think of
leukemia.
341b

BADRAWY MRCP Revision

Diagnosis of CLL

342a

BADRAWY MRCP Revision

immunophenotyping NOT
cytogenetics, NOT bone
marrow
342b

BADRAWY MRCP Revision

Prognostic factors for AML

343a

BADRAWY MRCP Revision

bm karyotype
(good/poor/standard)
343b

BADRAWY MRCP Revision

Pancytopenia with raised


MCV
344a

BADRAWY MRCP Revision

check B12/folate first


(other causes possible, but
do this FIRST). Often
associayed with phenytoin
use folate
344b

BADRAWY MRCP Revision

Anosmia, delayed puberty

345a

BADRAWY MRCP Revision

Kallmans syndrome
(hypogonadotrophic
hypogonadism)
345b

BADRAWY MRCP Revision

Commonest finding in
G6PD hamolysis
346a

BADRAWY MRCP Revision

haemoglobinuria

346b

BADRAWY MRCP Revision

Flank pain,
urinalysis:blood, protein
347a

BADRAWY MRCP Revision

renal vein thrombosis.


Causes: nephrotic
syndrome, RCC, amyloid,
acute pyelonephritis, SLE
,atiphospholipid syndrome
347b

BADRAWY MRCP Revision

Anemia in the elderly


assume
348a

BADRAWY MRCP Revision

GI malignancy

348b

BADRAWY MRCP Revision

Diptheria

349a

BADRAWY MRCP Revision

exudative pharyngitis,
lymphadenopathy, cardio
and neuro toxicity.
349b

BADRAWY MRCP Revision

Indurated plaques on
cheeks, scarring alopecia,
hyperkeratosis over hair
follicles
350a

BADRAWY MRCP Revision

Discoid LUPUS

350b

BADRAWY MRCP Revision

Wt loss, malabsoption, inc


ALP
351a

BADRAWY MRCP Revision

pancreatic cancer

351b

BADRAWY MRCP Revision

Wt loss, anemia
(macro/micro), no obvious
cause
352a

BADRAWY MRCP Revision

coeliac (diarrhea does NOT


have to be present)
352b

BADRAWY MRCP Revision

Hematuria, proteinuria,
best investigation
353a

BADRAWY MRCP Revision

if glomerulonephritis
suspected renal biopsy
353b

BADRAWY MRCP Revision

Venous ulcer treatment

354a

BADRAWY MRCP Revision

exclude arteriopathy (eg


ABPI), control edema,
prevent infection,
compression bandaging.
354b

BADRAWY MRCP Revision

Fever, lymphadenopathy,
lymphocytosis, pharygitis
355a

BADRAWY MRCP Revision

EBV heterophile
antibodies
355b

BADRAWY MRCP Revision

GI bleed after endovascular


AAA Surgery
356a

BADRAWY MRCP Revision

aortoenteric fistula

356b

BADRAWY MRCP Revision

Functional
hypogonadotrophic
hypogonadism
357a

BADRAWY MRCP Revision

amennorhea. LH and FSH


both low.
All other hormones are
usually normal. Ferritin
low.
357b

BADRAWY MRCP Revision

Vitiligo - commonest
assoctions
358a

BADRAWY MRCP Revision

pernicious anemia type 1


DM , autoimmune
addisons, autoimmune
thyoid
358b

BADRAWY MRCP Revision

Peripheral neuropathy

359a

BADRAWY MRCP Revision

a) B12 - rapid, dorsal columns (joint pos,


vibration), sensory
ataxia, pseudoathetosis of upperlimbs
b) diabetic - slow, spinothalamic (pain,
temp?)
c)alcohol - slow progressive, spinothalamic
d) Pb - motor upper limbs
359b

BADRAWY MRCP Revision

CNS abnormalities in HIV

360a

BADRAWY MRCP Revision

toxoplaasmosis (multiple ring


enhancing), lymphoma (solitary
lesion). HIV encephalopathy,
progressive multifocal
leucoencephalopathy (PML demylination in advanced HIV, low
attenuation lesions)
360b

BADRAWY MRCP Revision

Travellers diarrohea

361a

BADRAWY MRCP Revision

chronic (>2 WEEKS) giardia


(incidious onset rx.
Metronidazole),
SALMONELLA (serious systemic
illness), E.coli (rx. Ciprofloxacin)
, Shigella
361b

BADRAWY MRCP Revision

If you see blood on


urinalysis forget about
362a

BADRAWY MRCP Revision

RAS

362b

BADRAWY MRCP Revision

Fasciculations

363a

BADRAWY MRCP Revision

Motor neurone diease

363b

BADRAWY MRCP Revision

Silvery white scale

364a

BADRAWY MRCP Revision

PSORIASIS

364b

BADRAWY MRCP Revision

Hypopigmented

365a

BADRAWY MRCP Revision

vitiligo/pityriasis versicolor

365b

BADRAWY MRCP Revision

Pretibial myxedema

366a

BADRAWY MRCP Revision

Graves

366b

BADRAWY MRCP Revision

R. Arthritis with nephritic


syndrome
367a

BADRAWY MRCP Revision

looks for amyloidosis, even


by rectal biopsy.
367b

BADRAWY MRCP Revision

Your valuable comments


are highly appreciated.
368a

BADRAWY MRCP Revision

Thank You

368b

Das könnte Ihnen auch gefallen